CVS HEALTH Corp (CVS) stock
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 19/3031% below fair value
$89.79+0.27 (+0.30%)
Close on Nov 12, 2026Market cap $114.84BP/E 10.5Yield 2.96%
Cvs Health profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Cvs Health's profit margin for the twelve months ending Sep 30, 2026 was 2.6%. For fiscal 2025 it was 0.4%, against 1.2% the year before. The highest annual figure on record is 3.8% in fiscal 2009.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0.4% | −0.8 |
| FY2024 | Dec 31, 2024 | 1.2% | −1.1 |
| FY2023 | Dec 31, 2023 | 2.3% | +1.0 |
| FY2022 | Dec 31, 2022 | 1.3% | −1.4 |
| FY2021 | Dec 31, 2021 | 2.7% | +0.1 |
| FY2020 | Dec 31, 2020 | 2.7% | +0.1 |
| FY2019 | Dec 31, 2019 | 2.6% | +2.9 |
| FY2018 | Dec 31, 2018 | -0.3% | −3.9 |
| FY2017 | Dec 31, 2017 | 3.6% | +0.6 |
| FY2016 | Dec 31, 2016 | 3.0% | −0.4 |
| FY2015 | Dec 31, 2015 | 3.4% | +0.1 |
| FY2014 | Dec 31, 2014 | 3.3% | −0.2 |
| FY2010 | Dec 31, 2010 | 3.6% | −0.2 |
| FY2009 | Dec 31, 2009 | 3.8% | +0.1 |
| FY2008 | Dec 31, 2008 | 3.7% | +0.2 |
| FY2007 | Dec 29, 2007 | 3.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 2.0% | +5.9 |
| Q2 FY2026 | Jun 30, 2026 | 2.8% | +1.8 |
| Q1 FY2026 | Mar 31, 2026 | 2.9% | +1.0 |
| Q4 FY2025 | Dec 31, 2025 | 2.8% | +1.1 |
| Q3 FY2025 | Sep 30, 2025 | -3.9% | −4.0 |
| Q2 FY2025 | Jun 30, 2025 | 1.0% | −0.9 |
| Q1 FY2025 | Mar 31, 2025 | 1.9% | +0.6 |
| Q4 FY2024 | Dec 31, 2024 | 1.7% | −0.5 |
| Q3 FY2024 | Sep 30, 2024 | 0.1% | −2.4 |
| Q2 FY2024 | Jun 30, 2024 | 1.9% | −0.2 |
| Q1 FY2024 | Mar 31, 2024 | 1.3% | −1.2 |
| Q4 FY2023 | Dec 31, 2023 | 2.2% | −0.6 |
| Q3 FY2023 | Sep 30, 2023 | 2.5% | +6.7 |
| Q2 FY2023 | Jun 30, 2023 | 2.1% | −1.6 |
| Q1 FY2023 | Mar 31, 2023 | 2.5% | −0.6 |
| Q4 FY2022 | Dec 31, 2022 | 2.8% | +1.0 |
| Q3 FY2022 | Sep 30, 2022 | -4.2% | −6.4 |
| Q2 FY2022 | Jun 30, 2022 | 3.8% | −0.1 |
| Q1 FY2022 | Mar 31, 2022 | 3.1% | −0.2 |
| Q4 FY2021 | Dec 31, 2021 | 1.8% | +0.4 |
| Q3 FY2021 | Sep 30, 2021 | 2.2% | +0.3 |
| Q2 FY2021 | Jun 30, 2021 | 3.8% | −0.7 |
| Q1 FY2021 | Mar 31, 2021 | 3.2% | +0.2 |
| Q4 FY2020 | Dec 31, 2020 | 1.4% | −1.2 |
| Q3 FY2020 | Sep 30, 2020 | 1.8% | −0.5 |
| Q2 FY2020 | Jun 30, 2020 | 4.6% | +1.5 |
| Q1 FY2020 | Mar 31, 2020 | 3.0% | +0.7 |
| Q4 FY2019 | Dec 31, 2019 | 2.6% | +3.4 |
| Q3 FY2019 | Sep 30, 2019 | 2.4% | −0.6 |
| Q2 FY2019 | Jun 30, 2019 | 3.1% | +8.5 |
| Q1 FY2019 | Mar 31, 2019 | 2.3% | +0.1 |
| Q4 FY2018 | Dec 31, 2018 | -0.8% | −7.6 |
| Q3 FY2018 | Sep 30, 2018 | 2.9% | +0.1 |
| Q2 FY2018 | Jun 30, 2018 | -5.5% | −7.9 |
| Q1 FY2018 | Mar 31, 2018 | 2.2% | +0.0 |
| Q4 FY2017 | Dec 31, 2017 | 6.8% | +3.1 |
| Q3 FY2017 | Sep 30, 2017 | 2.8% | – |
| Q2 FY2017 | Jun 30, 2017 | 2.4% | – |
| Q1 FY2017 | Mar 31, 2017 | 2.1% | – |
| Q4 FY2016 | Dec 31, 2016 | 3.7% | – |
See a number that looks wrong?